[1]
Yaacob, N.; Hamzah, N.; Nursyazni, N.; Mohamed, N.; Amalina, S.; Abidin, Z. Anticancer activity of a sub-fraction of dichloromethane extract of Strobilanthes crispus on human breast and prostate cancer cells in vitro. BMC Complement. Altern. Med., 2010, 10, 42.
[2]
Jemal, A.; Bray, F.; Ferlay, J. Global cancer statistics. CA Cancer J. Clin., 2011, 61, 69-90.
[3]
Solowey, E.; Lichtenstein, M.; Sallon, S.; Paavilainen, H.; Solowey, E.; Lorberboum-Galski, H. Evaluating medicinal plants for anticancer activity. ScientificWorldJournal, 2014, 2014721402
[4]
Papo, N.; Shai, Y. New lytic peptides based on the D, L-amphipathic helix motif preferentially kill tumor cells compared to normal cells. J. Biol. Chem., 2003, 42(31), 9346-9354.
[5]
Papo, N.; Shai, Y. Host defense peptides as new weapons in cancer treatment. Cell. Mol. Life Sci. Vis. Ref., 2005, 62, 784-790.
[6]
Pierpaoli, E.; Damiani, E.; Orlando, F.; Lucarini, G.; Bartozzi, B.; Lombardi, P.; Salvatore, C.; Geroni, C.; Provinciali, M. Antiangiogenic and antitumor activities of berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma. Carcinogenesis, 2015, 36, 1169-1179.
[7]
Chen, X.; Zhang, M.; Fan, P.; Qin, Y.; Zhao, H. Chelerythrine chloride induces apoptosis in renal cancer HEK-293 and SW-839 cell lines. Oncol. Lett., 2016, 42(31), 3917-3924.
[8]
Lu, S.; Nishimura, S.; Ito, M.; Tsuchida, T.; Kakeya, H. Isolation and structure elucidation of cytotoxic saccharothriolides D to F from a rare actinomycete Saccharothrix sp. and their structure-activity relationship. J. Nat. Prod., 2016, 79(7), 1891-1895.
[9]
Schweizer, F. Cationic amphiphilic peptides with cancer-selective toxicity. Eur. J. Pharmacol., 2009, 625, 190-194.
[10]
Romero, M.; Renard, P.; Caignard, D.; Atassi, G.; Solans, X.; Constans, P.; Bailly, C.; Pujol, M. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs. J. Med. Chem., 2007, 50, 294-307.
[11]
Newman, D.; Cragg, G. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod., 2007, 70, 461-477.
[12]
Tillhon, M.; Guamán, L.; Lombardi, P.; Scovassi, A. Berberine: New perspectives for old remedies. Biochem. Pharmacol., 2012, 84, 1260-1267.
[13]
Lahlou, M. The success of natural products in drug discovery. J. Pharm. Pharmacol., 2013, 4, 17-31.
[14]
Tan, Y.; Sun, X.; Dong, F.; Tian, H.; Jiang, R. Enhancing the structural diversity and bioactivity of natural products by combinatorial modification exemplified by total tanshinones. Chin. J. Chem., 2015, 33, 1084-1088.
[15]
Mônica, S.; De Almeida, V.; Lafayette, E.; De Oliveira, T.; Lucia, A.; Gois, T.; De Carvalho, J. Synthesis, DNA binding, and antiproliferative activity of novel acridine-thiosemicarbazone derivatives. Int. J. Mol. Sci., 2015, 16, 13023-13042.
[16]
Hai-ning, Y.; Zun-chen, W.; Sheng-rong, S.; Wei-guang, S. Effects of capsaicin and its analogs on the growth of gastric cancer cells and their structure-activity relationships in vitro. . Food Sci. Technol. Int., 2013, 19, 865-873.
[17]
Grycová, L.; Dostál, J.; Marek, R. Quaternary protoberberine alkaloids. Phytochemistry, 2007, 68, 150-175.
[18]
Martínez-Martínez, F.; Razo-Hernádez, R.; Pereza-Campos, A.; Villanueva-García, M.; Sumaya-Martínez, M.; Jaramillo-Cano, D.; Gómez-Sandoval, Z. Synthesis and in vitro antioixidant activity evaluation of 3-carboxycoumarin derivatives and QSAR study of their DPPH radical scavenging activity. Molecules, 2012, 17, 14882-14898.
[19]
Leyva-Peralta, M.; Robles-Zepeda, R.; Garibay-Escobar, A.; Ruiz-Bustos, E.; Alvarez-Berber, L.; Gálvez-Ruiz, J. In vitro anti-proliferative activity of Argemone gracilenta and identification of some active components. BMC Complement. Altern. Med., 2015, 15, 1-7.
[20]
Pierpaoli, E.; Arcamone, A.; Buzzetti, F.; Lombardi, P.; Salvatore, C.; Provinciali, M. Antitumor effect of novel berberine derivatives in breast cancer cells. Biofactors, 2013, 39, 672-679.
[21]
Miguel, L.; Ortiz, G.; Tillhon, M.; Parks, M.; Dutto, I.; Prosperi, E.; Savio, M.; Arcamone, A.; Buzzetti, F.; Lombardi, P.; Scovassi, A. Multiple effects of berberine derivatives on colon cancer cells. BioMed Res. Int., 2014, 2014924585
[22]
Bengtsson, C.; Nelander, H.; Almqvist, F. Asymmetric synthesis of 2,4,5-trisubstituted Δ 2-thiazolines. Chem. Eur. J., 2013, 19, 9916-9922.
[23]
Zhang, Y.; Zimmerman, S. Azobenzene dye-coupled quadruply hydrogenbonding modules as colorimetric indicators for supramolecular interactions. Beilstein J. Org. Chem., 2012, 8, 486-495.
[24]
Bhupendra, M.; Young-Soo, K.; Doo Hwan, K. Synthesis, antioxidant and anticancer screenings of berberine-indole conjugates. Res. Chem. Intermed., 2015, 42, 3241-3256.
[25]
Bhupendra, M.; Rahul, V.; Young-Soo, K.; Doo Hwan, K. Evaluation of the biological potencies of newly synthesized berberine derivatives bearing benzothiazole moieties with substituted functionalities. J. Saudi Chem. Soc., 2017, 21, 210-219.
[26]
Bhupendra, M.; Rahul, V.; Young-Soo, K.; Doo Hwan, K. Synthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects. Saudi J. Biol. Sci., 2017, 24, 36-44.
[27]
Simic, M.; Damjanovic, A.; Kalinic, M.; Tasic, G.; Slavica, M.; Antic-Stankovic, J.; Savic, V. Synthesis, cytotoxicity and computational study of novel protoberberine derivatives. J. Serb. Chem. Soc., 2016, 81, 103-123.
[28]
Viswanadhan, V.; Ghose, A.; Revankar, G.; Robins, R. Atomic physicochemical parameter for three dimensional structure directed quantitative structure-activity relationships, 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J. Chem. Inf. Model., 1989, 29, 163-172.
[29]
Todeschina, R.; Consonni, V.; Mauri, A.; Pavan, M. Detecting “bad” regression model: Multicriteria fitness functions in regression analysis. Anal. Chim. Acta, 2004, 515, 199-208.
[30]
Roy, K.; Narayan, R. Statiscal methods in QSAR/QPSR. A primer on QSAR/QPSR modeling; Springer: Berlin, 2015. Chapter 2.
[31]
Noolvi, M.; Patel, H. A comparative QSAR analysis and molecular docking studies of quinazoline derivatives as tyrosine kinase (EGFR) inhibitors: A rational approach to anticancer drug desing. J. Saudi Chem. Soc., 2013, 17, 361-379.
[32]
Zydek, G.; Brzezinska, E. Development and validation of quantitative structure-activity relationship models for compound acting on serotoninergic receptors. ScientificWorldJournal, 2012, 2012, 157950
[33]
Pal, K.; Pore, S.; Sinha, S.; Janardhanan, R.; Mukhopadhyay, D.; Banerjee, R. Structure-activity study to develop cationic lipid-conjugated haloperidol derivatives as a new class of anticancer therapeutics. J. Med. Chem., 2011, 54(7), 2378-2390.
[34]
Chhikara, B.; Mandal, D.; Parang, K. Synthesis, anticancer activities, and cellular uptake studies of lipophilic derivatives of doxorubicin succinate. J. Med. Chem., 2012, 55(4), 1500-1510.
[35]
Wang, M.; Wang, F.; Xu, F.; Ding, L-Q.; Qiu, F. Two pairs of farnesyl phenolic enantiomers as natural nitric oxide inhibitors from Ganoderma sinense. Bioorg. Med. Chem. Lett., 2016, 26, 3342-3345.
[36]
Liu, J-Q.; Lian, Ch-L.; Hu, T-Y.; Wang, C-F.; Cheng, B-H. Two new farnesyl phenolic compounds with anti-inflammatory activities from Ganoderma duripora. Food Chem., 2018, 263, 155-162.
[37]
Islam, M.T.; Ali, E.S.; Uddin, S.J.; Shaw, S.; Atanasov, A.G. Phytol: A review of biomedical activities. Food Chem. Toxicol., 2018, 121, 82-94.
[38]
Raju, R.; Singh, A.; Reddell, P.; Münch, G. Anti-inflammatory activity of prenyl and geranyloxy furanocoumarins from Citrus garrawayi (Rutaceae). Phytochem. Lett., 2018, 27, 197-202.
[39]
Mo, H.; Tatman, D.; Jung, M.; Elson, C.E. Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomas. Cancer Lett., 2000, 157, 145-153.
[40]
Suparji, N.S.; Chan, G.; Sapili, H.; Arshad, N.M. In, L.L.; Awang, K.; Nagoor, N.H. Geranylated 4-Phenylcoumarins exhibit anticancer effects against human prostate cancer cells through caspase-independent mechanism. PLoS One, 2016, 11(3)e0151472
[41]
Hosseinymehr, M.; Matin, M.M.; Sadeghian, H.; Bahrami, A.R.; Kaseb-Mojaver, N. 8-Farnesyloxycoumarin induces apoptosis in PC-3 prostate cancer cells by inhibition of 15-lipoxygenase-1 enzymatic activity. Anticancer Drugs, 2016, 9, 854-862.
[42]
Bartmańska, A.; Tronina, T.; Popłoński, J.; Milczarek, M.; Filip-Psurska, B.; Wietrzyk, J. Highly cancer selective antiproliferative activity of natural prenylated flavonoids. Molecules, 2018, 23(11)E2922
[43]
Wätjen, W.; Weber, N.; Lou, Y.J.; Wang, Z.Q.; Chovolou, Y.; Kampkötter, A.; Kahl, R.; Proksch, P. Prenylation enhances cytotoxicity of apigenin and liquiritigenin in rat H4IIE hepatoma and C6 glioma cells. Food Chem. Toxicol., 2007, 45, 119-124.
[44]
Wang, H.M.; Zhang, L.; Liu, J.; Yang, Z.L.; Zhao, H.Y.; Yang, Y.; Shen, D.; Lu, K.; Fan, Z.C.; Yao, Q.W.; Zhang, Y.M.; Teng, Y.O.; Peng, Y. Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs. Eur. J. Med. Chem., 2015, 92, 439-448.
[45]
Offerman, S.C.; Kadirvel, M.; Abusara, O.H.; Bryant, J.L.; Telfer, B.A.; Brown, G.; Freeman, S.; White, A.; Williams, K.J.; Aojula, H.S. N-tert-Prenylation of the indole ring improves the cytotoxicity of a short antagonist G analogue against small cell lung cancer. MedChemComm, 2017, 8, 551-558.
[46]
Shiozawa, M.; Iida, K.; Odagi, M.; Yamanaka, M.; Nagasawa, K. Synthesis of 2,6,7-Trisubstituted prenylated indole. J. Org. Chem., 2018, 83, 7276-7280.
[47]
Johnston, S.R.D. Farnesyl transferase inhibitors: A novel targeted therapy for cancer. Lancet Oncol., 2001, 2, 18-26.
[48]
Schlitzer, M.; Sattler, I. Aromatic carboxylic acids as farnesyl surrogates in farnesyl pyrophosphate-based farnesyltransferase inhibitors. Bioorg. Med. Chem., 1999, 7, 2391-2395.
[49]
Eros, D.; Kovesdi, L.; Orfi, K.; Takacs-Novak, G.; Acsady, G.; Keri, G. Reliability of logP predictions based on calculated molecular descriptors: A critical review. . Curr. Med. Chem., 2002, 9, 1819-1829.
